What is Artesunate 120 Injection?
Artesunate 120 Injection is a potent antimalarial medication formulated for intravenous use. It contains the active ingredient Artesunate, derived from the plant Artemisia annua, which also yields Artemisinin 450 mg capsules. This injection is primarily used for the treatment of severe malaria cases, especially those caused by Plasmodium falciparum, the most dangerous malaria parasite. Manufactured by Zydus Cadila Pharma, Artesunate 120 Injection ensures high purity and efficacy, conforming to stringent pharmaceutical standards.
In Canada and other countries with malaria risks, Artesunate 120 Injection plays a critical role in saving lives by rapidly eliminating the malaria parasite from the bloodstream. Its fast-acting properties make it essential for hospital settings where immediate treatment is required. This product is an important part of antimalarial therapy protocols recommended by health authorities worldwide.
Uses of Artesunate 120 Injection
- Treatment of severe falciparum malaria
- Management of complicated malaria infections resistant to oral antimalarials such as Mefloquine 250 Mg
- Rapid reduction of parasite load in patients with cerebral malaria
- Prevention of mortality associated with severe malaria cases
How Artesunate 120 Injection Works
Artesunate 120 Injection works by quickly targeting the malaria parasites present in red blood cells. Once administered, Artesunate is rapidly converted into its active metabolite, dihydroartemisinin, which produces free radicals. These free radicals damage proteins and cellular structures inside the parasite, leading to its death. The drug effectively disrupts the parasite's lifecycle, preventing further multiplication and spread within the host.
This mechanism of action allows Artesunate 120 Injection to act faster than many other antimalarials, including quinine, as shown in artesunate versus quinine trials, helping reduce symptoms and complications associated with severe malaria. Its distinct mode of action is highly valuable in treating resistant strains of malaria, often encountered in tropical and subtropical regions.
Benefits of Artesunate 120 Injection
- Rapid parasite clearance and symptom relief
- Effective against drug-resistant malaria strains, alongside combination options like Synriam
- Useful in critically ill patients unable to take oral medications
- Reduces malaria-related mortality rates
- Produces minimal adverse effects when administered correctly
Dosage and Administration
Artesunate 120 Injection should be administered under medical supervision, usually in a hospital setting. The dosage depends on patient weight, severity of malaria, and clinical response. Typically, an initial intravenous dose of 2.4 mg/kg is given at 0, 12, and 24 hours, followed by daily doses for the next 3 to 7 days as needed. It is important to complete the full treatment course to prevent recurrence.
After stabilization, patients may transition to oral antimalarial drugs such as Proguanil 100 mg to complete therapy. Only qualified healthcare professionals should handle dosing adjustments and monitor the patient for any adverse reactions or complications during treatment.
Who Should Use Artesunate 120 Injection?
Artesunate 120 Injection is intended for patients diagnosed with severe malaria, especially those with complications such as cerebral malaria or multi-organ involvement. It is suitable for adults and children who require rapid intervention and cannot tolerate oral antimalarial drugs like quinine sulphate due to vomiting or unconsciousness. Healthcare practitioners may prescribe this medication to travelers or residents in malaria-endemic areas presenting with life-threatening symptoms.
Who Should Avoid Artesunate 120 Injection?
Patients with known hypersensitivity to Artesunate or any of its components should avoid this injection. Use caution in patients with underlying liver or kidney impairment, as close monitoring is necessary. Artesunate 120 Injection is not recommended for uncomplicated malaria cases where oral medications are appropriate. Pregnant and breastfeeding women should only use this medication when the potential benefits outweigh risks and under strict medical supervision.
Side Effects
- Nausea
- Vomiting
- Headache
- Dizziness
- Injection site pain
- Allergic reactions including rash
- Transient low blood cell counts
- Elevated liver enzymes
Safety Advice
- Use only under qualified medical supervision
- Inform your doctor about any allergies
- Notify if you experience signs of allergic reaction
- Complete the full prescribed course
- Avoid self-medication or dosage changes
- Regular monitoring of blood counts and liver function may be required
- Do not share the injection with others
Drug Interactions
- Avoid co-administration with other artemisinin derivatives such as Artesunate injection 60mg unless directed
- Use caution with drugs metabolized by the liver enzyme CYP450 system
- Consult healthcare provider before combining with antiretroviral or antitubercular agents
- Inform your doctor about all concurrent medications
Storage Instructions
Store Artesunate 120 Injection in a cool, dry place protected from light. Maintain storage temperature between 2°C and 8°C (refrigeration). Do not freeze. Keep the vial tightly closed and out of reach of children. Use the injection immediately after reconstitution as directed to maintain potency and sterility.
Where to buy Artesunate 120 Injection in Canada?
Artesunate 120 Injection can be purchased through licensed pharmacies and healthcare facilities in Canada. It is often available in hospitals equipped for treating malaria. For private purchase, ensure to obtain from authorized distributors to guarantee product authenticity and safety. Health insurance providers may cover the cost if prescribed for severe malaria treatment. Always consult a healthcare professional before buying this medication.
Frequently Asked Questions (FAQ)
Is Artesunate 120 Injection available in Canada?
Yes, Artesunate 120 Injection is available in Canada, primarily for hospital use in treating severe malaria. Access through authorized medical providers is essential.
What is the price of Artesunate 120 Injection in Canada?
The price varies depending on the supplier and healthcare facility. Typically, price information is available only through pharmacies or hospitals due to prescription requirements.
What happens if I miss a dose?
Missing a dose can reduce treatment effectiveness. Contact your healthcare provider immediately to adjust your treatment plan appropriately.
Where can I find Artesunate 120 Injection for sale?
This injection is sold via licensed pharmacies and hospitals. Purchasing from unauthorized sources is discouraged to avoid counterfeit products.
Can Artesunate 120 Injection be used for uncomplicated malaria?
No, it is intended for severe malaria cases only; uncomplicated malaria is generally treated with oral antimalarial medications.
Are there any age restrictions for Artesunate 120 Injection?
It can be used in both adults and children with severe malaria, but dosing must be carefully adjusted and supervised by healthcare professionals.
Is Artesunate 120 Injection safe during pregnancy?
Safety during pregnancy is not fully established; it should be used only when clearly needed and under strict medical supervision.
Conclusion
Artesunate 120 Injection from Zydus Cadila Pharma is a highly effective and fast-acting antimalarial treatment designed for severe malaria cases. Its ability to rapidly reduce parasite loads and improve outcomes makes it a critical medicine in malaria management. For patients in Canada and globally dealing with complicated malaria, Artesunate 120 Injection provides a reliable solution backed by scientific efficacy and stringent quality standards. Always consult a healthcare professional for proper diagnosis, usage, and monitoring to ensure safe and optimal treatment results.
Leave A Review